-
Product Insights
Acute Promyelocytic Leukemia - Drugs In Development, 2024
Empower your strategies with our Acute Promyelocytic Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. Acute Promyelocytic Leukemia is an aggressive blood cancer affecting the white blood cells known as promyelocytes which are immature white blood cells. It is characterized by thrombocytopenia (low platelets) resulting in thrombosis, excess bleeding, and anemia. It is a sub type of AML (acute myeloid leukemia) and is a medical emergency condition. Infections, bruises, bleeding are common symptoms and when examined...
-
Product Insights
Giant Cell Tumor Of Bone - Drugs In Development, 2024
Empower your strategies with our Giant Cell Tumor Of Bone – Drugs In Development, 2024 report and make more profitable business decisions. Giant Cell Tumor is a common benign tumor (non-cancerous) that grows at the long bones typically femur and tibia and knee joints. It is observed commonly in age groups 20-40 years. As name reflects the tumor cells appears giant in size. It can be aggressive and may spread to the surrounding bones in rare cases. Cause is unknown. But...
-
Product Insights
Paraganglioma (Glomus Jugulare Tumor) - Drugs In Development, 2024
Empower your strategies with our Paraganglioma (Glomus Jugulare Tumor) – Drugs In Development, 2024 report and make more profitable business decisions. Abnormal growth of chromaffin cells, a type of nerve cell found throughout the body leads to paraganglioma also known as glomus jugulare tumor. It is a rare form of neuroendocrine tumor. These tumors can be found in adrenal glands or outside of it especially in carotid artery. Cause is idiopathic. Headache, high blood pressure, faster pulse rate, sweating is some...
-
Product Insights
Paranasal Sinus And Nasal Cavity Cancer - Drugs In Development, 2024
Empower your strategies with our Paranasal Sinus And Nasal Cavity Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Malignant cells in the tissues of paranasal sinuses and nasal cavity results in paranasal sinus and nasal cavity cancer. It is rare type of cancer categorized into five stages (stage 0- stage 4) and of different types like adenocarcinoma, squamous cell carcinoma, melanoma, lymphoma, sarcoma etc. It can be metastasis in nature. Exposure to chemicals, dust, age, infections...
-
Product Insights
Carcinoid Tumor - Drugs In Development, 2024
Empower your strategies with our Carcinoid Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Carcinoid tumors are slow-growing tumors arising from neuroendocrine cells and capable of secreting a variety of peptides and neuroamines. The common primary sites are the gastrointestinal (GI) tract, tracheobronchial tree, ovaries, and kidneys. The most common location of carcinoids is the small intestine. The term carcinoid is usually used for well-differentiated and low- to intermediate-grade neuroendocrine tumors. The Carcinoid Tumor drugs in...
-
Product Insights
Craniopharyngioma - Drugs In Development, 2024
Empower your strategies with our Craniopharyngioma – Drugs In Development, 2024 report and make more profitable business decisions. Craniopharyngioma is a brain tumor that develops near the pituitary gland and the hypothalamus and is slow-growing and non-cancerous. Although these tumors are not cancerous, they may grow to press on nearby parts of the brain, causing symptoms including hormonal changes, vision alteration, headaches, nausea and vomiting, loss of balance, hearing loss, and changes in mood or behavior. The cause of these tumors...
-
Product Insights
Nongerminomatous (Nonseminomatous) Germ Cell Tumors - Drugs In Development, 2024
Empower your strategies with our Nongerminomatous (Nonseminomatous) Germ Cell Tumors – Drugs In Development, 2024 report and make more profitable business decisions. The most common type of testis cancer is a germ cell tumor (GCT). There are two main types of GCT, seminoma and nonseminomatous germ cell tumor (NSGCT). Both seminoma and NSGCT occur at about the same rate, and men can have seminoma, NSGCTs, or a combination of both. There are four main types of NSGCT that can appear alone,...
-
Product Insights
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) - Drugs In Development, 2024
Empower your strategies with our Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Gorlin syndrome, also known as basal cell nevous syndrome, is a condition that affects many areas of the body and increases the risk of developing various cancerous and noncancerous tumors. Symptoms include arrhythmia, medulloblastoma, ovarian fibromas, depressions in the skin, large head size and skeletal abnormalities involving the spine, ribs, or skull. Treatment...
-
Product Insights
Hormone Sensitive Breast Cancer - Drugs In Development, 2024
Empower your strategies with our Hormone Sensitive Breast Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Estrogen and progesterone promote the growth of some breast cancers, which are called hormone-sensitive (or hormone-dependent) breast cancers. Hormone-sensitive breast cancer cells contain proteins called hormone receptors (estrogen receptors, or ERs, and progesterone receptors, or PRs) that become activated when hormones bind to them. The activated receptors cause changes in the expression of specific genes, which can stimulate cell growth....
-
Product Insights
Primitive Neuroectodermal Tumor (PNET) - Drugs In Development, 2024
Empower your strategies with our Primitive Neuroectodermal Tumor (PNET) – Drugs In Development, 2024 report and make more profitable business decisions. Primitive neuroectodermal tumors (PNET) and pineoblastoma are a group of tumors defined by their appearance and are thought to develop from undeveloped nerve cells in the brain. They are aggressive tumors that tend to attach to parts of the brain that control movement, thought, and sensation. The Primitive Neuroectodermal Tumor (PNET) drugs in development market research report provide comprehensive information...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.